| Hearing Associates Inc | |
|
217 M St, Atchison, KS 66002-1463 | |
| (913) 384-5880 | |
| (913) 384-9612 |
| Full Name | Hearing Associates Inc |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 217 M St, Atchison, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457336745 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| 237700000X | Hearing Instrument Specialist | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Hearing Associates Inc 8901 W 74th St # 150, Shawnee Mission, KS 66204-2282 Ph: (913) 384-5880 | Hearing Associates Inc 217 M St, Atchison, KS 66002-1463 Ph: (913) 384-5880 |
News Archive
The U.S. Court of Appeals for the Federal Circuit has upheld the dismissal of the patent infringement lawsuit filed by Medtronic against BrainLAB AG in 1998.
A House panel on Thursday overwhelmingly approved legislation to overhaul Blue Cross Blue Shield of Michigan, leaving out anti-abortion provisions that torpedoed an earlier effort to change the status of the state's largest health insurer. The 11-0 votes signaled -; at least for now -; that one of Republican Gov. Rick Snyder's top legislative priorities could reach his desk without language that led him to veto similar legislation in late December. The Senate OK'd the new Blue Cross bills in late January.
A review of patients with oral eosinophilic ulcers suggests that the lesions should be considered a reactive, local condition rather than a CD30+ lymphoproliferative disorder.
Energy drinks might finally be facing a ban what with both the Australian Government and Opposition committing to handling the issue. The highly-caffeinated drink Mother is sold at 95 pubs and clubs across the state. This is despite NSW Health officials warning that energy drinks mixed with alcohol can provoke sexual assaults and an increased rate of violence.
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, today announced top line results from a clinical study showing that the novel inhaled therapeutic, PUR118, demonstrated anti-inflammatory efficacy and was well-tolerated in two Phase 1b studies in patients with chronic obstructive pulmonary disease (COPD).
› Verified 4 days ago